Ingenuity Blog
Your Molecule Has Met Its Match
Filter by:
Featured
Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing
OKLAHOMA CITY, March 11, 2023 — Cytovance Biologics and Phenotypeca Limited (Phenotypeca), a research and development organization with proprietary yeast expression technology that provides key advantages in recombinant protein manufacture, have entered into an agreement to provide optimized...
OKLAHOMA CITY, March 11, 2023 — Cytovance Biologics and Phenotypeca Limited (Phenotypeca), a research and development organization with proprietary yeast...
OKLAHOMA CITY, January 16, 2023 -- Cytovance Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and...
Any current Good Manufacturing Practice (cGMP) E.coli program must be based on a solid strain development strategy. This thought led...
The number and variety of protein therapeutics have increased dramatically in recent years. To satisfy therapeutic demand, these molecules must...
Process Characterization & Statistical Modeling — Transforming Data into Knowledge Throughout the Product Lifecycle, Upcoming Webinar Hosted by Xtalks. It’s...
Cytovance Biologics and Avantor Collaborate to Accelerate Plasmid DNA Development for Global Biopharma Market. Cytovance Biologics and Avantor will accelerate...
Cytovance Biologics, a global leading contract development and manufacturing provider of microbial, mammalian and plasmid DNA services in clinical and...
Cytovance Biologics announces the next webinar of its 2021 series: pDNA Manufacturing: An Optimized Platform Process. The webinar set for...
Cytovance® Biologics announces the next webinar of its 2021 series: pDNA Manufacturing: An Optimized Platform Process. The webinar set for...
Cytovance Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene therapy biologics, announces its...
OKLAHOMA CITY, January 16, 2023 -- Cytovance Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and...
Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass Spectrometry (Mass Spec) to...
End of content
No more pages to load